Gillian C. Ivers-Read

2021

In 2021, Gillian C. Ivers-Read earned a total compensation of $1.2M as EVP and Chief Regulatory Officer at Clovis Oncology, a 11% decrease compared to previous year.

Compensation breakdown

Bonus$185,754
Salary$492,940
Stock Awards$504,630
Other$28,368
Total$1,211,692

Ivers-Read received $504.6K in stock awards, accounting for 42% of the total pay in 2021.

Ivers-Read also received $185.8K in bonus, $492.9K in salary and $28.4K in other compensation.

Rankings

In 2021, Gillian C. Ivers-Read's compensation ranked 8,085th out of 12,415 executives tracked by ExecPay. In other words, Ivers-Read earned more than 34.9% of executives.

ClassificationRankingPercentile
All
8,085
out of 12,415
35th
Division
Manufacturing
3,575
out of 5,505
35th
Major group
Chemicals And Allied Products
1,587
out of 2,375
33rd
Industry group
Drugs
1,411
out of 2,096
33rd
Industry
Pharmaceutical Preparations
1,047
out of 1,546
32nd

Pay ratio

Gillian C. Ivers-Read's Pay$1,211,692
Median Employee's Pay$246,936
Pay Ratio

5

to 1

In 2021, the annual total compensation of Gillian C. Ivers-Read was $1,211,692.

The annual total compensation of the median employee at Clovis Oncology was $246,936.

The ratio of Gillian C. Ivers-Read's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 27, 2022.

Ivers-Read's colleagues

We found four more compensation records of executives who worked with Gillian C. Ivers-Read at Clovis Oncology in 2021.

2021

Patrick Mahaffy

Clovis Oncology

Chief Executive Officer

2021

Lindsey Rolfe

Clovis Oncology

Chief Medical Officer

2021

Paul Gross

Clovis Oncology

General Counsel

2021

Daniel Muehl

Clovis Oncology

Chief Financial Officer

News

You may also like